Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LYB005 RSV Vaccine in Older Adults
NCT07908654Phase 3Not yet recruiting
- Sponsor
- Patronus Biotech
- Start
- Nov 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 3 trial of LYB005 in respiratory syncytial virus infection (RSV), sponsored by Patronus Biotech. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
LYB005
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT07908654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07908654.